SCHEMBL6846708

SCHEMBL6846708

CC(O[C]=O)c1ccco1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
KMT2A Q03164 4/20 0.38
POLB P06746 4/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
PKM P14618 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN7 P35236 1/20 0.38
BLM P54132 1/20 0.38
ESR2 Q92731 1/20 0.38
ALDH1A1 P00352 7/20 0.37
MEN1 O00255 3/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
AGTR1 P30556 1/20 0.35
HPGD P15428 4/20 0.35
HSD17B10 Q99714 3/20 0.35
TP53 P04637 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5308503 0.79 KMT2A (0.41) ALOX5KMT2APOLBL3MBTL1PKM
SCHEMBL1153462 0.76 ALOX5 (0.41) ALOX5KMT2APOLBL3MBTL1PKM
SCHEMBL948260 0.72
SCHEMBL6846713 0.72 ALOX5 (0.40) ALOX5KMT2APOLBL3MBTL1PKM
SCHEMBL4829955 0.71 ALOX5 (0.38) ALOX5KMT2APOLBL3MBTL1PKM
SCHEMBL11536081 0.71 ALOX5 (0.39) ALOX5KMT2APOLBL3MBTL1PKM
SCHEMBL17789934 0.69 ALOX5 (0.37) ALOX5KMT2APOLBL3MBTL1PKM
SCHEMBL9091231 0.69 POLB (0.33) KMT2APOLBL3MBTL1PKMPTPN1
SCHEMBL1258862 0.69 ALOX5 (0.53) ALOX5KMT2APOLBL3MBTL1PKM
SCHEMBL8906046 0.69 POLB (0.40) ALOX5KMT2APOLBL3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242724-A1 Acid decomposable compound SAITO YUTAKA (JP) 2004-12-02 US disclosed
WO-1996004297-A9 SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS 1996-05-02 WO disclosed
EP-0601184-A1 FUSED PYRIDAZINE COMPOUND AND PHARMACEUTICAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1994-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242724-A1 Acid decomposable compound DERA, ALDOA, DHPS ALOX5 312/4885KMT2A 1926/4885POLB 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.